These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34026352)

  • 21. CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas.
    Wang B; Wei W; Long S; Wang L; Yang B; Wu D; Li Z; Li Z; Arshad M; Li X; Chen J
    Front Neurol; 2022; 13():1015221. PubMed ID: 36341103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
    Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
    BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
    Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC
    Front Oncol; 2019; 9():1433. PubMed ID: 31921684
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas.
    Zhu H; Ouyang H; Pan X; Zhang Z; Tan J; Yu N; Li M; Zhao Y
    Front Oncol; 2022; 12():912101. PubMed ID: 35875094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas.
    Bao Z; Zhang C; Yan W; Liu Y; Li M; Zhang W; Jiang T
    J Transl Med; 2013 Apr; 11():100. PubMed ID: 23590708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
    Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X
    J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis Analysis and Validation of m
    Lin S; Xu H; Zhang A; Ni Y; Xu Y; Meng T; Wang M; Lou M
    Front Oncol; 2020; 10():541401. PubMed ID: 33123464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrating Radiosensitivity Gene Signature Improves Glioma Outcome and Radiotherapy Response Prediction.
    Wu S; Xu J; Li G; Jin X
    Medicina (Kaunas); 2022 Sep; 58(10):. PubMed ID: 36295489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma.
    Xiao K; Liu Q; Peng G; Su J; Qin CY; Wang XY
    PeerJ; 2020; 8():e8312. PubMed ID: 31921517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of
    Wang H; Wang X; Xu L; Zhang J; Cao H
    Front Oncol; 2021; 11():551160. PubMed ID: 33959491
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
    Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
    BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma.
    Zhao J; Liu Z; Zheng X; Gao H; Li L
    Front Genet; 2021; 12():753680. PubMed ID: 34819946
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma.
    Qi Y; Yang X; Ji C; Tang C; Xie L
    Brain Sci; 2022 Jan; 12(2):. PubMed ID: 35203944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
    Xia P; Li Q; Wu G; Huang Y
    Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients.
    Tan J; Zhu H; Tang G; Liu H; Wanggou S; Cao Y; Xin Z; Zhou Q; Zhan C; Wu Z; Guo Y; Jiang Z; Zhao M; Ren C; Jiang X; Yin W
    Front Genet; 2021; 12():616507. PubMed ID: 33732284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas.
    Ren P; Wang JY; Zeng ZR; Li NX; Chen HL; Peng XG; Bhawal UK; Guo WZ
    Front Genet; 2022; 13():976356. PubMed ID: 36118887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma.
    Yun D; Wang X; Wang W; Ren X; Li J; Wang X; Liang J; Liu J; Fan J; Ren X; Zhang H; Shang G; Sun J; Chen L; Li T; Zhang C; Yu S; Yang X
    Front Oncol; 2022; 12():897702. PubMed ID: 35756689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.